Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor
Status:
COMPLETED
Trial end date:
2024-10-17
Target enrollment:
Participant gender:
Summary
This study will assess the safety and efficacy of multiple-dose of STSP-0601 for the treatment of bleeding episodes in hemophilia A or B patients with inhibitor.